These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 11789246)
1. [Effect of Saikosaponin-d on up-regulating GR mRNA expression and inhibiting cell growth in human leukemia cells]. Bu S; Xu J; Sun J Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 May; 20(5):350-2. PubMed ID: 11789246 [TBL] [Abstract][Full Text] [Related]
2. [Saikosaponin-d up-regulates GR mRNA expression and induces apoptosis in HL-60 cells]. Bu S; Xu J; Sun J Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):354-6. PubMed ID: 11721431 [TBL] [Abstract][Full Text] [Related]
3. Saikosaponin D acts against corticosterone-induced apoptosis via regulation of mitochondrial GR translocation and a GR-dependent pathway. Li ZY; Jiang YM; Liu YM; Guo Z; Shen SN; Liu XM; Pan RL Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():80-9. PubMed ID: 24636912 [TBL] [Abstract][Full Text] [Related]
4. Effect of saikosaponin, a triterpene saponin, on apoptosis in lymphocytes: association with c-myc, p53, and bcl-2 mRNA. Hsu MJ; Cheng JS; Huang HC Br J Pharmacol; 2000 Dec; 131(7):1285-93. PubMed ID: 11090099 [TBL] [Abstract][Full Text] [Related]
5. The effects of saikosaponin on macrophage functions and lymphocyte proliferation. Ushio Y; Abe H Planta Med; 1991 Dec; 57(6):511-4. PubMed ID: 1818339 [TBL] [Abstract][Full Text] [Related]
6. Involvement of p-15(INK4b) and p-16(INK4a) gene expression in saikosaponin a and TPA-induced growth inhibition of HepG2 cells. Wu WS; Hsu HY Biochem Biophys Res Commun; 2001 Jul; 285(2):183-7. PubMed ID: 11444823 [TBL] [Abstract][Full Text] [Related]
7. Cell type-oriented differential modulatory actions of saikosaponin-d on growth responses and DNA fragmentation of lymphocytes triggered by receptor-mediated and receptor-bypassed pathways. Kato M; Pu MY; Isobe K; Hattori T; Yanagita N; Nakashima I Immunopharmacology; 1995 Apr; 29(3):207-13. PubMed ID: 7622352 [TBL] [Abstract][Full Text] [Related]
8. Saikosaponin b2-induced apoptosis of cultured B16 melanoma cell line through down-regulation of PKC activity. Zong Z; Fujikawa-Yamamoto K; Tanino M; Teraoka K; Yamagishi H; Odashima S Biochem Biophys Res Commun; 1996 Feb; 219(2):480-5. PubMed ID: 8605013 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of measles virus and herpes simplex virus by saikosaponin d. Ushio Y; Abe H Planta Med; 1992 Apr; 58(2):171-3. PubMed ID: 1529029 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the immunoregulatory action of saikosaponin-d. Kato M; Pu MY; Isobe K; Iwamoto T; Nagase F; Lwin T; Zhang YH; Hattori T; Yanagita N; Nakashima I Cell Immunol; 1994 Nov; 159(1):15-25. PubMed ID: 7954839 [TBL] [Abstract][Full Text] [Related]
11. Saikosaponin D disrupts platelet-derived growth factor-β receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: a potential mechanism of hepatotoxicity. Chen L; Zhang F; Kong D; Zhu X; Chen W; Wang A; Zheng S Chem Biol Interact; 2013 Oct; 206(1):76-82. PubMed ID: 23994742 [TBL] [Abstract][Full Text] [Related]
12. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways. Ma X; Dang C; Kang H; Dai Z; Lin S; Guan H; Liu X; Wang X; Hui W Int Immunopharmacol; 2015 Sep; 28(1):399-408. PubMed ID: 26118633 [TBL] [Abstract][Full Text] [Related]
13. Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway. Cai C; Zhang H; Ou Y; Jiang Y; Zhong D; Qi H; Dang Q Neoplasma; 2017; 64(4):518-525. PubMed ID: 28485157 [TBL] [Abstract][Full Text] [Related]
14. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Hsu YL; Kuo PL; Lin CC Life Sci; 2004 Jul; 75(10):1231-42. PubMed ID: 15219811 [TBL] [Abstract][Full Text] [Related]
15. Saikosaponin‑d inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase. Yao M; Yang J; Cao L; Zhang L; Qu S; Gao H Mol Med Rep; 2014 Jul; 10(1):365-72. PubMed ID: 24736800 [TBL] [Abstract][Full Text] [Related]
16. Estrogen-like activities of saikosaponin-d in vitro: a pilot study. Wang P; Ren J; Tang J; Zhang D; Li B; Li Y Eur J Pharmacol; 2010 Jan; 626(2-3):159-65. PubMed ID: 19819234 [TBL] [Abstract][Full Text] [Related]
17. [Effect of saikosaponin-d on rat's glomerular mesangial cell proliferation and extracellular matrix hyperplasia in vitro]. Zu N; Dong X; Fu GX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Apr; 27(4):321-5. PubMed ID: 17526171 [TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. Feng R; Shen S; Hui H; Jin M Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416 [TBL] [Abstract][Full Text] [Related]
19. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines. Hsu YL; Kuo PL; Chiang LC; Lin CC Cancer Lett; 2004 Sep; 213(2):213-21. PubMed ID: 15327837 [TBL] [Abstract][Full Text] [Related]
20. Patensin-induced apoptosis is accompanied by decreased bcl-2 expression and telomerase activity in HL-60 cells. Ji ZN; Ye WC; Rui J; Wang L; Liu GQ J Asian Nat Prod Res; 2004 Jun; 6(2):107-14. PubMed ID: 15008457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]